{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T11:46:06Z","timestamp":1792323966107,"version":"4.4.0"},"reference-count":150,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,4,21]],"date-time":"2015-04-21T00:00:00Z","timestamp":1429574400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1038\/nrrheum.2015.48","type":"journal-article","created":{"date-parts":[[2015,4,22]],"date-time":"2015-04-22T06:24:54Z","timestamp":1429683894000},"page":"462-474","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":268,"title":["A look behind the scenes: the risk and pathogenesis of primary osteoporosis"],"prefix":"10.1038","volume":"11","author":[{"given":"Gretl","family":"Hendrickx","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveline","family":"Boudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Van Hul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,21]]},"reference":[{"key":"BFnrrheum201548_CR1","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1007\/s00198-009-0920-3","volume":"20","author":"B Abrahamsen","year":"2009","unstructured":"Abrahamsen, B., van Staa, T., Ariely, R., Olson, M. & Cooper, C. Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos. Int. 20, 1633\u20131650 (2009).","journal-title":"Osteoporos. Int."},{"key":"BFnrrheum201548_CR2","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nrrheum.2011.217","volume":"8","author":"JP van den Bergh","year":"2012","unstructured":"van den Bergh, J. P., van Geel, T. A. & Geusens, P. P. Osteoporosis, frailty and fracture: implications for case finding and therapy. Nat. Rev. Rheumatol. 8, 163\u2013172 (2012).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrrheum201548_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/jbmr.5650100202","volume":"10","author":"LJ Melton 3rd.","year":"1995","unstructured":"Melton, L. J. 3rd. How many women have osteoporosis now? J. Bone Miner. Res. 10, 175\u2013177 (1995).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrrheum201548_CR4","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/BF01626603","volume":"5","author":"A Randell","year":"1995","unstructured":"Randell, A. et al. Direct clinical and welfare costs of osteoporotic fractures in elderly men and women. Osteoporos. Int. 5, 427\u2013432 (1995).","journal-title":"Osteoporos. Int."},{"key":"BFnrrheum201548_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s00198-004-1811-2","volume":"16","author":"JA Kanis","year":"2005","unstructured":"Kanis, J. A. & Johnell, O. Requirements for DXA for the management of osteoporosis in Europe. Osteoporos. Int. 16, 229\u2013238 (2005).","journal-title":"Osteoporos. Int."},{"key":"BFnrrheum201548_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S1043-2760(00)00336-2","volume":"12","author":"LK Bachrach","year":"2001","unstructured":"Bachrach, L. K. Acquisition of optimal bone mass in childhood and adolescence. Trends Endocrinol. Metab. 12, 22\u201328 (2001).","journal-title":"Trends Endocrinol. Metab."},{"key":"BFnrrheum201548_CR7","doi-asserted-by":"crossref","unstructured":"Sapir-Koren, R. & Livshits, G. Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption-formation cycles? Osteoporos. Int. (2014).","DOI":"10.1007\/s00198-014-2808-0"},{"key":"BFnrrheum201548_CR8","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1007\/s00198-012-1909-x","volume":"23","author":"C Zuo","year":"2012","unstructured":"Zuo, C. et al. Osteoblastogenesis regulation signals in bone remodeling. Osteoporos. Int. 23, 1653\u20131663 (2012).","journal-title":"Osteoporos. Int."},{"key":"BFnrrheum201548_CR9","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/bonekey.2012.182","volume":"1","author":"P Garnero","year":"2012","unstructured":"Garnero, P. The contribution of collagen crosslinks to bone strength. Bonekey Rep. 1, 182 (2012).","journal-title":"Bonekey Rep."},{"key":"BFnrrheum201548_CR10","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s11914-014-0213-4","volume":"12","author":"T Alliston","year":"2014","unstructured":"Alliston, T. Biological regulation of bone quality. Curr. Osteoporos. Rep. 12, 366\u2013375 (2014).","journal-title":"Curr. Osteoporos. Rep."},{"key":"BFnrrheum201548_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11914-012-0103-6","volume":"10","author":"GE Sroga","year":"2012","unstructured":"Sroga, G. E. & Vashishth, D. Effects of bone matrix proteins on fracture and fragility in osteoporosis. Curr. Osteoporos. Rep. 10, 141\u2013150 (2012).","journal-title":"Curr. Osteoporos. Rep."},{"key":"BFnrrheum201548_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11914-006-0002-9","volume":"4","author":"ML Bouxsein","year":"2006","unstructured":"Bouxsein, M. L. & Karasik, D. Bone geometry and skeletal fragility. Curr. Osteoporos. Rep. 4, 49\u201356 (2006).","journal-title":"Curr. Osteoporos. Rep."},{"key":"BFnrrheum201548_CR13","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/bonekey.2012.102","volume":"1","author":"M Almeida","year":"2012","unstructured":"Almeida, M. Aging mechanisms in bone. Bonekey Rep. 1, 102 (2012).","journal-title":"Bonekey Rep."},{"key":"BFnrrheum201548_CR14","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1210\/er.2009-0024","volume":"31","author":"SC Manolagas","year":"2010","unstructured":"Manolagas, S. C. From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr. Rev. 31, 266\u2013300 (2010).","journal-title":"Endocr. Rev."},{"key":"BFnrrheum201548_CR15","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1126\/science.1070174","volume":"296","author":"J de Boer","year":"2002","unstructured":"de Boer, J. et al. Premature aging in mice deficient in DNA repair and transcription. Science 296, 1276\u20131279 (2002).","journal-title":"Science"},{"key":"BFnrrheum201548_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/415045a","volume":"415","author":"SD Tyner","year":"2002","unstructured":"Tyner, S. D. et al. p53 mutant mice that display early ageing-associated phenotypes. Nature 415, 45\u201353 (2002).","journal-title":"Nature"},{"key":"BFnrrheum201548_CR17","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1002\/jbmr.489","volume":"26","author":"H Nojiri","year":"2011","unstructured":"Nojiri, H. et al. Cytoplasmic superoxide causes bone fragility owing to low-turnover osteoporosis and impaired collagen cross-linking. J. Bone Miner. Res. 26, 2682\u20132694 (2011).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrrheum201548_CR18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.bbrc.2010.11.006","volume":"403","author":"MJ Smietana","year":"2010","unstructured":"Smietana, M. J., Arruda, E. M., Faulkner, J. A., Brooks, S. V. & Larkin, L. M. Reactive oxygen species on bone mineral density and mechanics in Cu, Zn superoxide dismutase (Sod1) knockout mice. Biochem. Biophys. Res. Commun. 403, 149\u2013153 (2010).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrrheum201548_CR19","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.cmet.2009.12.009","volume":"11","author":"E Ambrogini","year":"2010","unstructured":"Ambrogini, E. et al. FoxO-mediated defense against oxidative stress in osteoblasts is indispensable for skeletal homeostasis in mice. Cell Metab. 11, 136\u2013146 (2010).","journal-title":"Cell Metab."},{"key":"BFnrrheum201548_CR20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.bone.2011.05.023","volume":"49","author":"M Almeida","year":"2011","unstructured":"Almeida, M. Unraveling the role of FoxOs in bone\u2014insights from mouse models. Bone 49, 319\u2013327 (2011).","journal-title":"Bone"},{"key":"BFnrrheum201548_CR21","doi-asserted-by":"publisher","first-page":"27298","DOI":"10.1074\/jbc.M702811200","volume":"282","author":"M Almeida","year":"2007","unstructured":"Almeida, M., Han, L., Martin-Millan, M., O'Brien, C. A. & Manolagas, S. C. Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting \u03b2-catenin from T cell factor- to forkhead box O-mediated transcription. J. Biol. Chem. 282, 27298\u201327305 (2007).","journal-title":"J. Biol. Chem."},{"key":"BFnrrheum201548_CR22","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1126\/science.1109083","volume":"308","author":"MA Essers","year":"2005","unstructured":"Essers, M. A. et al. Functional interaction between \u03b2-catenin and FOXO in oxidative stress signaling. Science 308, 1181\u20131184 (2005).","journal-title":"Science"},{"key":"BFnrrheum201548_CR23","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/46311","volume":"402","author":"E Migliaccio","year":"1999","unstructured":"Migliaccio, E. et al. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 402, 309\u2013313 (1999).","journal-title":"Nature"},{"key":"BFnrrheum201548_CR24","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1126\/science.1069004","volume":"295","author":"S Nemoto","year":"2002","unstructured":"Nemoto, S. & Finkel, T. Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science 295, 2450\u20132452 (2002).","journal-title":"Science"},{"key":"BFnrrheum201548_CR25","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.cell.2005.05.011","volume":"122","author":"M Giorgio","year":"2005","unstructured":"Giorgio, M. et al. Electron. transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 122, 221\u2013233 (2005).","journal-title":"Cell"},{"key":"BFnrrheum201548_CR26","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1128\/MCB.24.4.1747-1757.2004","volume":"24","author":"S Pacini","year":"2004","unstructured":"Pacini, S. et al. p66SHC promotes apoptosis and antagonizes mitogenic signaling in T cells. Mol. Cell Biol. 24, 1747\u20131757 (2004).","journal-title":"Mol. Cell Biol."},{"issue":"Suppl. 1","key":"BFnrrheum201548_CR27","first-page":"S85","volume":"26","author":"SM Bartell","year":"2011","unstructured":"Bartell, S. M. et al. Deletion of the redox amplifier p66shc decreases ROS production in murine bone and increases osteoblast resistance to oxidative stress and bone mass [abstract]. J. Bone Miner. Res. 26 (Suppl. 1), S85 (2011).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrrheum201548_CR28","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1101\/gad.1162404","volume":"18","author":"B Maier","year":"2004","unstructured":"Maier, B. et al. Modulation of mammalian life span by the short isoform of p53. Genes Dev. 18, 306\u2013319 (2004).","journal-title":"Genes Dev."},{"key":"BFnrrheum201548_CR29","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1083\/jcb.200507106","volume":"172","author":"X Wang","year":"2006","unstructured":"Wang, X. et al. p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling. J. Cell Biol. 172, 115\u2013125 (2006).","journal-title":"J. Cell Biol."},{"issue":"Suppl. 1","key":"BFnrrheum201548_CR30","first-page":"S348","volume":"27","author":"RL Jilka","year":"2012","unstructured":"Jilka, R. L. et al. Dysfunctional osteocytes increase RANKL and promote cortical pore formation in their vicinity: a mechanistic explanation for the development of cortical porosity with age [abstract]. J. Bone Miner. Res. 27 (Suppl. 1), S348 (2012).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrrheum201548_CR31","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/jbmr.2007","volume":"29","author":"RL Jilka","year":"2014","unstructured":"Jilka, R. L. et al. Dysapoptosis of osteoblasts and osteocytes increases cancellous bone formation but exaggerates bone porosity with age. J. Bone Miner. Res. 29, 103\u2013117 (2014).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrrheum201548_CR32","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1359\/jbmr.1998.13.8.1243","volume":"13","author":"A Tomkinson","year":"1998","unstructured":"Tomkinson, A., Gevers, E. F., Wit, J. M., Reeve, J. & Noble, B. S. The role of estrogen in the control of rat osteocyte apoptosis. J. Bone Miner. Res. 13, 1243\u20131250 (1998).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrrheum201548_CR33","doi-asserted-by":"publisher","first-page":"27285","DOI":"10.1074\/jbc.M702810200","volume":"282","author":"M Almeida","year":"2007","unstructured":"Almeida, M. et al. Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J. Biol. Chem. 282, 27285\u201327297 (2007).","journal-title":"J. Biol. Chem."},{"key":"BFnrrheum201548_CR34","first-page":"3128","volume":"82","author":"A Tomkinson","year":"1997","unstructured":"Tomkinson, A., Reeve, J., Shaw, R. W. & Noble, B. S. The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J. Clin. Endocrinol. Metab. 82, 3128\u20133135 (1997).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrrheum201548_CR35","doi-asserted-by":"crossref","unstructured":"Frost, H. M. Micropetrosis. J. Bone Joint Surg. Am. 42-A, 144\u2013150 (1960).","DOI":"10.2106\/00004623-196042010-00012"},{"key":"BFnrrheum201548_CR36","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1111\/j.1474-9726.2010.00633.x","volume":"9","author":"B Busse","year":"2010","unstructured":"Busse, B. et al. Decrease in the osteocyte lacunar density accompanied by hypermineralized lacunar occlusion reveals failure and delay of remodeling in aged human bone. Aging Cell 9, 1065\u20131075 (2010).","journal-title":"Aging Cell"},{"key":"BFnrrheum201548_CR37","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.bone.2011.11.021","volume":"50","author":"VT Carpentier","year":"2012","unstructured":"Carpentier, V. T. et al. Increased proportion of hypermineralized osteocyte lacunae in osteoporotic and osteoarthritic human trabecular bone: implications for bone remodeling. Bone 50, 688\u2013694 (2012).","journal-title":"Bone"},{"key":"BFnrrheum201548_CR38","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/nrendo.2013.179","volume":"9","author":"SC Manolagas","year":"2013","unstructured":"Manolagas, S. C., O'Brien, C. A. & Almeida, M. The role of estrogen and androgen receptors in bone health and disease. Nat. Rev. Endocrinol. 9, 699\u2013712 (2013).","journal-title":"Nat. Rev. Endocrinol."},{"key":"BFnrrheum201548_CR39","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1056\/NEJMp038101","volume":"349","author":"E Seeman","year":"2003","unstructured":"Seeman, E. Periosteal bone formation\u2014a neglected determinant of bone strength. N. Engl. J. Med. 349, 320\u2013323 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFnrrheum201548_CR40","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1210\/me.2009-0354","volume":"24","author":"M Martin-Millan","year":"2010","unstructured":"Martin-Millan, M. et al. The estrogen receptor-\u03b1 in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone. Mol. Endocrinol. 24, 323\u2013334 (2010).","journal-title":"Mol. Endocrinol."},{"key":"BFnrrheum201548_CR41","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.cell.2007.07.025","volume":"130","author":"T Nakamura","year":"2007","unstructured":"Nakamura, T. et al. Estrogen prevents bone loss via estrogen receptor \u03b1 and induction of Fas ligand in osteoclasts. Cell 130, 811\u2013823 (2007).","journal-title":"Cell"},{"key":"BFnrrheum201548_CR42","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1359\/jbmr.081217","volume":"24","author":"C Chiang","year":"2009","unstructured":"Chiang, C. et al. Mineralization and bone resorption are regulated by the androgen receptor in male mice. J. Bone Miner. Res. 24, 621\u2013631 (2009).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrrheum201548_CR43","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1359\/jbmr.061117","volume":"22","author":"AJ Notini","year":"2007","unstructured":"Notini, A. J. et al. Osteoblast deletion of exon 3 of the androgen receptor gene results in trabecular bone loss in adult male mice. J. Bone Miner. Res. 22, 347\u2013356 (2007).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrrheum201548_CR44","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1002\/jbmr.1713","volume":"27","author":"M Sinnesael","year":"2012","unstructured":"Sinnesael, M. et al. Androgen receptor (AR) in osteocytes is important for the maintenance of male skeletal integrity: evidence from targeted AR disruption in mouse osteocytes. J. Bone Miner. Res. 27, 2535\u20132543 (2012).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrrheum201548_CR45","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1359\/jbmr.091017","volume":"25","author":"M Almeida","year":"2010","unstructured":"Almeida, M. et al. Estrogens attenuate oxidative stress and the differentiation and apoptosis of osteoblasts by DNA-binding-independent actions of the ER\u03b1. J. Bone Miner. Res. 25, 769\u2013781 (2010).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrrheum201548_CR46","first-page":"719","volume":"104","author":"S Kousteni","year":"2001","unstructured":"Kousteni, S. et al. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104, 719\u2013730 (2001).","journal-title":"Cell"},{"key":"BFnrrheum201548_CR47","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1126\/science.1074935","volume":"298","author":"S Kousteni","year":"2002","unstructured":"Kousteni, S. et al. Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science 298, 843\u2013846 (2002).","journal-title":"Science"},{"key":"BFnrrheum201548_CR48","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1074\/jbc.M111.294959","volume":"287","author":"N Marathe","year":"2012","unstructured":"Marathe, N., Rangaswami, H., Zhuang, S., Boss, G. R. & Pilz, R. B. Pro-survival effects of 17\u03b2-estradiol on osteocytes are mediated by nitric oxide\/cGMP via differential actions of cGMP-dependent protein kinases I and II. J. Biol. Chem. 287, 978\u2013988 (2012).","journal-title":"J. Biol. Chem."},{"key":"BFnrrheum201548_CR49","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1016\/S0140-6736(02)08706-8","volume":"359","author":"E Seeman","year":"2002","unstructured":"Seeman, E. Pathogenesis of bone fragility in women and men. Lancet 359, 1841\u20131850 (2002).","journal-title":"Lancet"},{"key":"BFnrrheum201548_CR50","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1210\/er.2004-0013","volume":"26","author":"JM Kaufman","year":"2005","unstructured":"Kaufman, J. M. & Vermeulen, A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr. Rev. 26, 833\u2013876 (2005).","journal-title":"Endocr. Rev."},{"key":"BFnrrheum201548_CR51","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.bone.2011.11.010","volume":"50","author":"M Shahnazari","year":"2012","unstructured":"Shahnazari, M. et al. Bone turnover markers in peripheral blood and marrow plasma reflect trabecular bone loss but not endocortical expansion in aging mice. Bone 50, 628\u2013637 (2012).","journal-title":"Bone"},{"key":"BFnrrheum201548_CR52","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1002\/jbmr.129","volume":"25","author":"FA Syed","year":"2010","unstructured":"Syed, F. A. et al. Effects of chronic estrogen treatment on modulating age-related bone loss in female mice. J. Bone Miner. Res. 25, 2438\u20132446 (2010).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrrheum201548_CR53","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/S0140-6736(10)60320-0","volume":"375","author":"RM Zebaze","year":"2010","unstructured":"Zebaze, R. M. et al. Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional study. Lancet 375, 1729\u20131736 (2010).","journal-title":"Lancet"},{"key":"BFnrrheum201548_CR54","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.bone.2012.09.017","volume":"54","author":"SC Manolagas","year":"2013","unstructured":"Manolagas, S. C. & Parfitt, A. M. For whom the bell tolls: distress signals from long-lived osteocytes and the pathogenesis of metabolic bone diseases. Bone 54, 272\u2013278 (2013).","journal-title":"Bone"},{"key":"BFnrrheum201548_CR55","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1002\/jbmr.1668","volume":"27","author":"LJ Hocking","year":"2012","unstructured":"Hocking, L. J., Whitehouse, C. & Helfrich, M. H. Autophagy: a new player in skeletal maintenance? J. Bone Miner. Res. 27, 1439\u20131447 (2012).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrrheum201548_CR56","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nrendo.2014.35","volume":"10","author":"KH Kim","year":"2014","unstructured":"Kim, K. H. & Lee, M. S. Autophagy\u2014a key player in cellular and body metabolism. Nat. Rev. Endocrinol. 10, 322\u2013337 (2014).","journal-title":"Nat. Rev. Endocrinol."},{"key":"BFnrrheum201548_CR57","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1002\/jbmr.36","volume":"25","author":"L Zhang","year":"2010","unstructured":"Zhang, L. et al. Pathway-based genome-wide association analysis identified the importance of regulation-of-autophagy pathway for ultradistal radius BMD. J. Bone Miner. Res. 25, 1572\u20131580 (2010).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrrheum201548_CR58","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.cell.2011.07.030","volume":"146","author":"DC Rubinsztein","year":"2011","unstructured":"Rubinsztein, D. C., Marino, G. & Kroemer, G. Autophagy and aging. Cell 146, 682\u2013695 (2011).","journal-title":"Cell"},{"key":"BFnrrheum201548_CR59","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1126\/science.1177221","volume":"326","author":"C Selman","year":"2009","unstructured":"Selman, C. et al. Ribosomal protein S6 kinase 1 signaling regulates mammalian life span. Science 326, 140\u2013144 (2009).","journal-title":"Science"},{"key":"BFnrrheum201548_CR60","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1042\/BST0370232","volume":"37","author":"YY Chang","year":"2009","unstructured":"Chang, Y. Y. et al. Nutrient-dependent regulation of autophagy through the target of rapamycin pathway. Biochem. Soc. Trans. 37, 232\u2013236 (2009).","journal-title":"Biochem. Soc. Trans."},{"key":"BFnrrheum201548_CR61","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.devcel.2011.08.016","volume":"21","author":"CJ DeSelm","year":"2011","unstructured":"DeSelm, C. J. et al. Autophagy proteins regulate the secretory component of osteoclastic bone resorption. Dev. Cell 21, 966\u2013974 (2011).","journal-title":"Dev. Cell"},{"key":"BFnrrheum201548_CR62","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1002\/jbmr.1971","volume":"28","author":"F Liu","year":"2013","unstructured":"Liu, F. et al. Suppression of autophagy by FIP200 deletion leads to osteopenia in mice through the inhibition of osteoblast terminal differentiation. J. Bone Miner. Res. 28, 2414\u20132430 (2013).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrrheum201548_CR63","doi-asserted-by":"publisher","first-page":"17432","DOI":"10.1074\/jbc.M112.444190","volume":"288","author":"M Onal","year":"2013","unstructured":"Onal, M. et al. Suppression of autophagy in osteocytes mimics skeletal aging. J. Biol. Chem. 288, 17432\u201317440 (2013).","journal-title":"J. Biol. Chem."},{"key":"BFnrrheum201548_CR64","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/07315724.2013.816604","volume":"32","author":"JP Bonjour","year":"2013","unstructured":"Bonjour, J. P., Kraenzlin, M., Levasseur, R., Warren, M. & Whiting, S. Dairy in adulthood: from foods to nutrient interactions on bone and skeletal muscle health. J. Am. Coll. Nutr. 32, 251\u2013263 (2013).","journal-title":"J. Am. Coll. Nutr."},{"key":"BFnrrheum201548_CR65","doi-asserted-by":"publisher","first-page":"396541","DOI":"10.1155\/2013\/396541","volume":"2013","author":"S Christodoulou","year":"2013","unstructured":"Christodoulou, S., Goula, T., Ververidis, A. & Drosos, G. Vitamin D and bone disease. Biomed. Res. Int. 2013, 396541 (2013).","journal-title":"Biomed. Res. Int."},{"key":"BFnrrheum201548_CR66","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/bonekey.2013.233","volume":"3","author":"JA Eisman","year":"2014","unstructured":"Eisman, J. A. & Bouillon, R. Vitamin D: direct effects of vitamin D metabolites on bone: lessons from genetically modified mice. Bonekey Rep. 3, 499 (2014).","journal-title":"Bonekey Rep."},{"key":"BFnrrheum201548_CR67","doi-asserted-by":"crossref","unstructured":"Rajendran, P. et al. Antioxidants and human diseases. Clin. Chim. Acta 436C, 332\u2013347 (2014).","DOI":"10.1016\/j.cca.2014.06.004"},{"key":"BFnrrheum201548_CR68","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.nutres.2012.09.018","volume":"32","author":"CL Shen","year":"2012","unstructured":"Shen, C. L. et al. Fruits and dietary phytochemicals in bone protection. Nutr. Res. 32, 897\u2013910 (2012).","journal-title":"Nutr. Res."},{"key":"BFnrrheum201548_CR69","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1017\/S1368980012001127","volume":"16","author":"JJ Li","year":"2013","unstructured":"Li, J. J. et al. Fruit and vegetable intake and bone mass in Chinese adolescents, young and postmenopausal women. Public Health Nutr. 16, 78\u201386 (2013).","journal-title":"Public Health Nutr."},{"key":"BFnrrheum201548_CR70","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1093\/ajcn\/71.1.142","volume":"71","author":"SA New","year":"2000","unstructured":"New, S. A. et al. Dietary influences on bone mass and bone metabolism: further evidence of a positive link between fruit and vegetable consumption and bone health? Am. J. Clin. Nutr. 71, 142\u2013151 (2000).","journal-title":"Am. J. Clin. Nutr."},{"key":"BFnrrheum201548_CR71","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1093\/ajcn\/83.6.1420","volume":"83","author":"CJ Prynne","year":"2006","unstructured":"Prynne, C. J. et al. Fruit and vegetable intakes and bone mineral status: a cross sectional study in 5 age and sex cohorts. Am. J. Clin. Nutr. 83, 1420\u20131428 (2006).","journal-title":"Am. J. Clin. Nutr."},{"key":"BFnrrheum201548_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.maturitas.2006.05.001","volume":"56","author":"PA Zalloua","year":"2007","unstructured":"Zalloua, P. A. et al. Impact of seafood and fruit consumption on bone mineral density. Maturitas 56, 1\u201311 (2007).","journal-title":"Maturitas"},{"key":"BFnrrheum201548_CR73","doi-asserted-by":"publisher","first-page":"1567S","DOI":"10.1093\/ajcn\/87.5.1567S","volume":"87","author":"RP Heaney","year":"2008","unstructured":"Heaney, R. P. & Layman, D. K. Amount and type of protein influences bone health. Am. J. Clin. Nutr. 87, 1567S\u20131570S (2008).","journal-title":"Am. J. Clin. Nutr."},{"key":"BFnrrheum201548_CR74","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1093\/ajcn\/82.5.921","volume":"82","author":"A Sebastian","year":"2005","unstructured":"Sebastian, A. Dietary protein content and the diet's net acid load: opposing effects on bone health. Am. J. Clin. Nutr. 82, 921\u2013922 (2005).","journal-title":"Am. J. Clin. Nutr."},{"key":"BFnrrheum201548_CR75","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1017\/S0007114513000962","volume":"110","author":"JP Bonjour","year":"2013","unstructured":"Bonjour, J. P. Nutritional disturbance in acid-base balance and osteoporosis: a hypothesis that disregards the essential homeostatic role of the kidney. Br. J. Nutr. 110, 1168\u20131177 (2013).","journal-title":"Br. J. Nutr."},{"key":"BFnrrheum201548_CR76","doi-asserted-by":"publisher","first-page":"F216","DOI":"10.1152\/ajpcell.1996.271.4.C1025","volume":"271","author":"DA Bushinsky","year":"1996","unstructured":"Bushinsky, D. A. Metabolic alkalosis decreases bone calcium efflux by suppressing osteoclasts and stimulating osteoblasts. Am. J. Physiol. 271, F216\u2013F222 (1996).","journal-title":"Am. J. Physiol."},{"key":"BFnrrheum201548_CR77","doi-asserted-by":"publisher","first-page":"829","DOI":"10.2174\/0929867013372896","volume":"8","author":"C Leeuwenburgh","year":"2001","unstructured":"Leeuwenburgh, C. & Heinecke, J. W. Oxidative stress and antioxidants in exercise. Curr. Med. Chem. 8, 829\u2013838 (2001).","journal-title":"Curr. Med. Chem."},{"key":"BFnrrheum201548_CR78","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nrrheum.2009.239","volume":"6","author":"E Ozcivici","year":"2010","unstructured":"Ozcivici, E. et al. Mechanical signals as anabolic agents in bone. Nat. Rev. Rheumatol. 6, 50\u201359 (2010).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrrheum201548_CR79","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s00198-010-1194-5","volume":"21","author":"GY Rochefort","year":"2010","unstructured":"Rochefort, G. Y., Pallu, S. & Benhamou, C. L. Osteocyte: the unrecognized side of bone tissue. Osteoporos. Int. 21, 1457\u20131469 (2010).","journal-title":"Osteoporos. Int."},{"key":"BFnrrheum201548_CR80","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/hmg\/10.5.537","volume":"10","author":"W Balemans","year":"2001","unstructured":"Balemans, W. et al. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum. Mol. Genet. 10, 537\u2013543 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrrheum201548_CR81","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/jmg.39.2.91","volume":"39","author":"W Balemans","year":"2002","unstructured":"Balemans, W. et al. Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease. J. Med. Genet. 39, 91\u201397 (2002).","journal-title":"J. Med. Genet."},{"key":"BFnrrheum201548_CR82","doi-asserted-by":"publisher","first-page":"19883","DOI":"10.1074\/jbc.M413274200","volume":"280","author":"X Li","year":"2005","unstructured":"Li, X. et al. Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling. J. Biol. Chem. 280, 19883\u201319887 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnrrheum201548_CR83","doi-asserted-by":"publisher","first-page":"26770","DOI":"10.1074\/jbc.M504308200","volume":"280","author":"M Semenov","year":"2005","unstructured":"Semenov, M., Tamai, K. & He, X. SOST is a ligand for LRP5\/LRP6 and a Wnt signaling inhibitor. J. Biol. Chem. 280, 26770\u201326775 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnrrheum201548_CR84","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.semarthrit.2013.01.004","volume":"43","author":"E Boudin","year":"2013","unstructured":"Boudin, E., Fijalkowski, I., Piters, E. & Van Hul, W. The role of extracellular modulators of canonical Wnt signaling in bone metabolism and diseases. Semin. Arthritis Rheum. 43, 220\u2013240 (2013).","journal-title":"Semin. Arthritis Rheum."},{"key":"BFnrrheum201548_CR85","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2741\/4214","volume":"19","author":"Y Wang","year":"2014","unstructured":"Wang, Y. et al. Wnt and the Wnt signaling pathway in bone development and disease. Front. Biosci. (Landmark Ed.) 19, 379\u2013407 (2014).","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"BFnrrheum201548_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00198-011-1787-7","volume":"23","author":"DB Maurel","year":"2012","unstructured":"Maurel, D. B., Boisseau, N., Benhamou, C. L. & Jaffre, C. Alcohol and bone: review of dose effects and mechanisms. Osteoporos. Int. 23, 1\u201316 (2012).","journal-title":"Osteoporos. Int."},{"key":"BFnrrheum201548_CR87","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11914-011-0049-0","volume":"9","author":"MJ Ronis","year":"2011","unstructured":"Ronis, M. J., Mercer, K. & Chen, J. R. Effects of nutrition and alcohol consumption on bone loss. Curr. Osteoporos. Rep. 9, 53\u201359 (2011).","journal-title":"Curr. Osteoporos. Rep."},{"key":"BFnrrheum201548_CR88","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/jbmr.7","volume":"25","author":"JR Chen","year":"2010","unstructured":"Chen, J. R. et al. A role for ethanol-induced oxidative stress in controlling lineage commitment of mesenchymal stromal cells through inhibition of Wnt\/\u03b2-catenin signaling. J. Bone Miner. Res. 25, 1117\u20131127 (2010).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrrheum201548_CR89","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1124\/jpet.107.130351","volume":"324","author":"JR Chen","year":"2008","unstructured":"Chen, J. R., Shankar, K., Nagarajan, S., Badger, T. M. & Ronis, M. J. Protective effects of estradiol on ethanol-induced bone loss involve inhibition of reactive oxygen species generation in osteoblasts and downstream activation of the extracellular signal-regulated kinase\/signal transducer and activator of transcription 3\/receptor activator of nuclear factor-\u03baB ligand signaling cascade. J. Pharmacol. Exp. Ther. 324, 50\u201359 (2008).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnrrheum201548_CR90","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00198-004-1640-3","volume":"16","author":"JA Kanis","year":"2005","unstructured":"Kanis, J. A. et al. Smoking and fracture risk: a meta-analysis. Osteoporos. Int. 16, 155\u2013162 (2005).","journal-title":"Osteoporos. Int."},{"key":"BFnrrheum201548_CR91","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/BF02390832","volume":"68","author":"KD Ward","year":"2001","unstructured":"Ward, K. D. & Klesges, R. C. A meta-analysis of the effects of cigarette smoking on bone mineral density. Calcif. Tissue Int. 68, 259\u2013270 (2001).","journal-title":"Calcif. Tissue Int."},{"key":"BFnrrheum201548_CR92","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1007\/s00198-012-1940-y","volume":"23","author":"V Yoon","year":"2012","unstructured":"Yoon, V., Maalouf, N. M. & Sakhaee, K. The effects of smoking on bone metabolism. Osteoporos. Int. 23, 2081\u20132092 (2012).","journal-title":"Osteoporos. Int."},{"key":"BFnrrheum201548_CR93","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1210\/jc.2013-1505","volume":"98","author":"JC Marini","year":"2013","unstructured":"Marini, J. C. & Blissett, A. R. New genes in bone development: what's new in osteogenesis imperfecta. J. Clin. Endocrinol. Metab. 98, 3095\u20133103 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrrheum201548_CR94","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/jmg.16.2.101","volume":"16","author":"DO Sillence","year":"1979","unstructured":"Sillence, D. O., Senn, A. & Danks, D. M. Genetic heterogeneity in osteogenesis imperfecta. J. Med. Genet. 16, 101\u2013116 (1979).","journal-title":"J. Med. Genet."},{"key":"BFnrrheum201548_CR95","unstructured":"OMIM\u00ae Online Mendelian Inheritance in Man\u00ae. An Online Catalog of Human Genes and Genetic Disorders [online] , (2015)."},{"key":"BFnrrheum201548_CR96","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1002\/ajmg.a.36545","volume":"164","author":"FS Van Dijk","year":"2014","unstructured":"Van Dijk, F. S. & Sillence, D. O. Osteogenesis imperfecta: Clinical diagnosis, nomenclature and severity assessment. Am. J. Med. Genet. A 164, 1470\u20131481 (2014).","journal-title":"Am. J. Med. Genet. A"},{"key":"BFnrrheum201548_CR97","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00198-013-2443-1","volume":"25","author":"S Lazarus","year":"2014","unstructured":"Lazarus, S., Zankl, A. & Duncan, E. L. Next-generation sequencing: a frameshift in skeletal dysplasia gene discovery. Osteoporos. Int. 25, 407\u2013422 (2014).","journal-title":"Osteoporos. Int."},{"key":"BFnrrheum201548_CR98","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/ajmg.a.33909","volume":"155A","author":"ML Warman","year":"2011","unstructured":"Warman, M. L. et al. Nosology and classification of genetic skeletal disorders: 2010 revision. Am. J. Med. Genet. A 155A, 943\u2013968 (2011).","journal-title":"Am. J. Med. Genet. A"},{"key":"BFnrrheum201548_CR99","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/ejhg.2011.141","volume":"20","author":"FS van Dijk","year":"2012","unstructured":"van Dijk, F. S. et al. EMQN best practice guidelines for the laboratory diagnosis of osteogenesis imperfecta. Eur. J. Hum. Genet. 20, 11\u201319 (2012).","journal-title":"Eur. J. Hum. Genet."},{"key":"BFnrrheum201548_CR100","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00198-013-2465-8","volume":"25","author":"S Lazarus","year":"2014","unstructured":"Lazarus, S., Moffatt, P., Duncan, E. L. & Thomas, G. P. A brilliant breakthrough in OI type V. Osteoporos. Int. 25, 399\u2013405 (2014).","journal-title":"Osteoporos. Int."},{"key":"BFnrrheum201548_CR101","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s00223-013-9723-9","volume":"93","author":"DR Eyre","year":"2013","unstructured":"Eyre, D. R. & Weis, M. A. Bone collagen: new clues to its mineralization mechanism from recessive osteogenesis imperfecta. Calcif. Tissue Int. 93, 338\u2013347 (2013).","journal-title":"Calcif. Tissue Int."},{"key":"BFnrrheum201548_CR102","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1159\/000055910","volume":"68","author":"J Gebken","year":"2000","unstructured":"Gebken, J. et al. Increased cell surface expression of receptors for transforming growth factor-\u03b2 on osteoblasts from patients with Osteogenesis imperfecta. Pathobiology 68, 106\u2013112 (2000).","journal-title":"Pathobiology"},{"key":"BFnrrheum201548_CR103","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/nm.3544","volume":"20","author":"I Grafe","year":"2014","unstructured":"Grafe, I. et al. Excessive transforming growth factor-\u03b2 signaling is a common mechanism in osteogenesis imperfecta. Nat. Med. 20, 670\u2013675 (2014).","journal-title":"Nat. Med."},{"key":"BFnrrheum201548_CR104","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ajhg.2010.05.016","volume":"87","author":"P Lapunzina","year":"2010","unstructured":"Lapunzina, P. et al. Identification of a frameshift mutation in Osterix in a patient with recessive osteogenesis imperfecta. Am. J. Hum. Genet. 87, 110\u2013114 (2010).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrrheum201548_CR105","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ajhg.2013.02.010","volume":"92","author":"K Keupp","year":"2013","unstructured":"Keupp, K. et al. Mutations in WNT1 cause different forms of bone fragility. Am. J. Hum. Genet. 92, 565\u2013574 (2013).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrrheum201548_CR106","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1056\/NEJMoa1215458","volume":"368","author":"CM Laine","year":"2013","unstructured":"Laine, C. M. et al. WNT1 mutations in early-onset osteoporosis and osteogenesis imperfecta. N. Engl. J. Med. 368, 1809\u20131816 (2013).","journal-title":"N. Engl. J. Med."},{"key":"BFnrrheum201548_CR107","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bone.2013.07.020","volume":"57","author":"S Fahiminiya","year":"2013","unstructured":"Fahiminiya, S. et al. Whole-exome sequencing reveals a heterozygous LRP5 mutation in a 6-year-old boy with vertebral compression fractures and low trabecular bone density. Bone 57, 41\u201346 (2013).","journal-title":"Bone"},{"key":"BFnrrheum201548_CR108","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-2350-13-26","volume":"13","author":"J Korvala","year":"2012","unstructured":"Korvala, J. et al. Mutations in LRP5 cause primary osteoporosis without features of OI by reducing Wnt signaling activity. BMC Med. Genet. 13, 26 (2012).","journal-title":"BMC Med. Genet."},{"key":"BFnrrheum201548_CR109","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1359\/JBMR.050705","volume":"20","author":"P Crabbe","year":"2005","unstructured":"Crabbe, P. et al. Missense mutations in LRP5 are not a common cause of idiopathic osteoporosis in adult men. J. Bone Miner. Res. 20, 1951\u20131959 (2005).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrrheum201548_CR110","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1056\/NEJMoa1308223","volume":"369","author":"FS van Dijk","year":"2013","unstructured":"van Dijk, F. S. et al. PLS3 mutations in X-linked osteoporosis with fractures. N. Engl. J. Med. 369, 1529\u20131536 (2013).","journal-title":"N. Engl. J. Med."},{"key":"BFnrrheum201548_CR111","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1002\/jbmr.2208","volume":"29","author":"S Fahiminiya","year":"2014","unstructured":"Fahiminiya, S. et al. Osteoporosis caused by mutations in PLS3: clinical and bone tissue characteristics. J. Bone Miner. Res. 29, 1805\u20131814 (2014).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrrheum201548_CR112","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1002\/ajmg.a.35278","volume":"158A","author":"CM Laine","year":"2012","unstructured":"Laine, C. M. et al. Primary osteoporosis without features of OI in children and adolescents: clinical and genetic characteristics. Am. J. Med. Genet. A 158A, 1252\u20131261 (2012).","journal-title":"Am. J. Med. Genet. A"},{"key":"BFnrrheum201548_CR113","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0092-8674(01)00571-2","volume":"107","author":"Y Gong","year":"2001","unstructured":"Gong, Y. et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107, 513\u2013523 (2001).","journal-title":"Cell"},{"key":"BFnrrheum201548_CR114","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/ajmg.a.33177","volume":"152A","author":"S Narumi","year":"2010","unstructured":"Narumi, S. et al. Various types of LRP5 mutations in four patients with osteoporosis-pseudoglioma syndrome: identification of a 7.2-kb microdeletion using oligonucleotide tiling microarray. Am. J. Med. Genet. A 152A, 133\u2013140 (2010).","journal-title":"Am. J. Med. Genet. A"},{"key":"BFnrrheum201548_CR115","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1210\/en.2006-1352","volume":"148","author":"W Balemans","year":"2007","unstructured":"Balemans, W. & Van Hul, W. The genetics of low-density lipoprotein receptor-related protein 5 in bone: a story of extremes. Endocrinology 148, 2622\u20132629 (2007).","journal-title":"Endocrinology"},{"key":"BFnrrheum201548_CR116","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1002\/humu.22133","volume":"33","author":"MT Puig-Hervas","year":"2012","unstructured":"Puig-Hervas, M. T. et al. Mutations in PLOD2 cause autosomal-recessive connective tissue disorders within the Bruck syndrome\u2014osteogenesis imperfecta phenotypic spectrum. Hum. Mutat. 33, 1444\u20131449 (2012).","journal-title":"Hum. Mutat."},{"key":"BFnrrheum201548_CR117","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1002\/ajmg.a.34025","volume":"155A","author":"R Shaheen","year":"2011","unstructured":"Shaheen, R. et al. Mutations in FKBP10 cause both Bruck syndrome and isolated osteogenesis imperfecta in humans. Am. J. Med. Genet. A 155A, 1448\u20131452 (2011).","journal-title":"Am. J. Med. Genet. A"},{"key":"BFnrrheum201548_CR118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/hmg\/dds371","volume":"22","author":"U Schwarze","year":"2013","unstructured":"Schwarze, U. et al. Mutations in FKBP10, which result in Bruck syndrome and recessive forms of osteogenesis imperfecta, inhibit the hydroxylation of telopeptide lysines in bone collagen. Hum. Mol. Genet. 22, 1\u201317 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrrheum201548_CR119","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1210\/edrv.23.3.0464","volume":"23","author":"M Peacock","year":"2002","unstructured":"Peacock, M., Turner, C. H., Econs, M. J. & Foroud, T. Genetics of osteoporosis. Endocr. Rev. 23, 303\u2013326 (2002).","journal-title":"Endocr. Rev."},{"key":"BFnrrheum201548_CR120","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1001\/jama.286.22.2815","volume":"286","author":"ES Siris","year":"2001","unstructured":"Siris, E. S. et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA 286, 2815\u20132822 (2001).","journal-title":"JAMA"},{"key":"BFnrrheum201548_CR121","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1210\/jc.2009-2406","volume":"95","author":"EL Duncan","year":"2010","unstructured":"Duncan, E. L. & Brown, M. A. Clinical review 2: Genetic determinants of bone density and fracture risk\u2014state of the art and future directions. J. Clin. Endocrinol. Metab. 95, 2576\u20132587 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrrheum201548_CR122","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1210\/er.2009-0044","volume":"31","author":"SH Ralston","year":"2010","unstructured":"Ralston, S. H. & Uitterlinden, A. G. Genetics of osteoporosis. Endocr. Rev. 31, 629\u2013662 (2010).","journal-title":"Endocr. Rev."},{"key":"BFnrrheum201548_CR123","doi-asserted-by":"publisher","first-page":"e1001372","DOI":"10.1371\/journal.pgen.1001372","volume":"7","author":"EL Duncan","year":"2011","unstructured":"Duncan, E. L. et al. Genome-wide association study using extreme truncate selection identifies novel genes affecting bone mineral density and fracture risk. PLoS Genet. 7, e1001372 (2011).","journal-title":"PLoS Genet."},{"key":"BFnrrheum201548_CR124","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ng.2249","volume":"44","author":"K Estrada","year":"2012","unstructured":"Estrada, K. et al. Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat. Genet. 44, 491\u2013501 (2012).","journal-title":"Nat. Genet."},{"key":"BFnrrheum201548_CR125","doi-asserted-by":"publisher","first-page":"e1002718","DOI":"10.1371\/journal.pgen.1002718","volume":"8","author":"C Medina-Gomez","year":"2012","unstructured":"Medina-Gomez, C. et al. Meta-analysis of genome-wide scans for total body BMD in children and adults reveals allelic heterogeneity and age-specific effects at the WNT16 locus. PLoS Genet. 8, e1002718 (2012).","journal-title":"PLoS Genet."},{"key":"BFnrrheum201548_CR126","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/S0140-6736(08)60599-1","volume":"371","author":"JB Richards","year":"2008","unstructured":"Richards, J. B. et al. Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet 371, 1505\u20131512 (2008).","journal-title":"Lancet"},{"key":"BFnrrheum201548_CR127","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/ng.446","volume":"41","author":"F Rivadeneira","year":"2009","unstructured":"Rivadeneira, F. et al. Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat. Genet. 41, 1199\u20131206 (2009).","journal-title":"Nat. Genet."},{"key":"BFnrrheum201548_CR128","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1056\/NEJMoa0801197","volume":"358","author":"U Styrkarsdottir","year":"2008","unstructured":"Styrkarsdottir, U. et al. Multiple genetic loci for bone mineral density and fractures. N. Engl. J. Med. 358, 2355\u20132365 (2008).","journal-title":"N. Engl. J. Med."},{"key":"BFnrrheum201548_CR129","doi-asserted-by":"publisher","first-page":"e13217","DOI":"10.1371\/journal.pone.0013217","volume":"5","author":"U Styrkarsdottir","year":"2010","unstructured":"Styrkarsdottir, U. et al. European bone mineral density loci are also associated with BMD in East-Asian populations. PLoS ONE 5, e13217 (2010).","journal-title":"PLoS ONE"},{"key":"BFnrrheum201548_CR130","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1093\/hmg\/ddt575","volume":"23","author":"L Zhang","year":"2014","unstructured":"Zhang, L. et al. Multistage genome-wide association meta-analyses identified two new loci for bone mineral density. Hum. Mol. Genet. 23, 1923\u20131933 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrrheum201548_CR131","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1093\/hmg\/ddt675","volume":"23","author":"A Moayyeri","year":"2014","unstructured":"Moayyeri, A. et al. Genetic determinants of heel bone properties: genome-wide association meta-analysis and replication in the GEFOS\/GENOMOS consortium. Hum. Mol. Genet. 23, 3054\u20133068 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrrheum201548_CR132","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.bone.2013.10.015","volume":"59","author":"L Oei","year":"2014","unstructured":"Oei, L. et al. Genome-wide association study for radiographic vertebral fractures: a potential role for the 16q24 BMD locus. Bone 59, 20\u201327 (2014).","journal-title":"Bone"},{"key":"BFnrrheum201548_CR133","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1136\/jmedgenet-2013-102064","volume":"51","author":"L Oei","year":"2014","unstructured":"Oei, L. et al. A genome-wide copy number association study of osteoporotic fractures points to the 6p25.1 locus. J. Med. Genet. 51, 122\u2013131 (2014).","journal-title":"J. Med. Genet."},{"key":"BFnrrheum201548_CR134","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1007\/s00198-010-1405-0","volume":"22","author":"S Chew","year":"2011","unstructured":"Chew, S. et al. Homozygous deletion of the UGT2B17 gene is not associated with osteoporosis risk in elderly Caucasian women. Osteoporos. Int. 22, 1981\u20131986 (2011).","journal-title":"Osteoporos. Int."},{"key":"BFnrrheum201548_CR135","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s00198-009-0998-7","volume":"21","author":"FY Deng","year":"2010","unstructured":"Deng, F. Y. et al. Genome-wide copy number variation association study suggested VPS13B gene for osteoporosis in Caucasians. Osteoporos. Int. 21, 579\u2013587 (2010).","journal-title":"Osteoporos. Int."},{"key":"BFnrrheum201548_CR136","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.ajhg.2008.10.006","volume":"83","author":"TL Yang","year":"2008","unstructured":"Yang, T. L. et al. Genome-wide copy-number-variation study identified a susceptibility gene, UGT2B17, for osteoporosis. Am. J. Hum. Genet. 83, 663\u2013674 (2008).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrrheum201548_CR137","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00198-011-1671-5","volume":"23","author":"C Holroyd","year":"2012","unstructured":"Holroyd, C., Harvey, N., Dennison, E. & Cooper, C. Epigenetic influences in the developmental origins of osteoporosis. Osteoporos. Int. 23, 401\u2013410 (2012).","journal-title":"Osteoporos. Int."},{"key":"BFnrrheum201548_CR138","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1515\/cclm-2013-0770","volume":"52","author":"P Vrtacnik","year":"2014","unstructured":"Vrtacnik, P., Marc, J. & Ostanek, B. Epigenetic mechanisms in bone. Clin. Chem. Lab. Med. 52, 589\u2013608 (2014).","journal-title":"Clin. Chem. Lab. Med."},{"key":"BFnrrheum201548_CR139","doi-asserted-by":"publisher","first-page":"252","DOI":"10.2174\/138920212800543129","volume":"13","author":"J Delgado-Calle","year":"2012","unstructured":"Delgado-Calle, J., Garmilla, P. & Riancho, J. A. Do epigenetic marks govern bone mass and homeostasis? Curr. Genomics 13, 252\u2013263 (2012).","journal-title":"Curr. Genomics"},{"key":"BFnrrheum201548_CR140","doi-asserted-by":"publisher","first-page":"4514","DOI":"10.1210\/en.2011-1128","volume":"152","author":"E Cohen-Kfir","year":"2011","unstructured":"Cohen-Kfir, E. et al. Sirt1 is a regulator of bone mass and a repressor of Sost encoding for sclerostin, a bone formation inhibitor. Endocrinology 152, 4514\u20134524 (2011).","journal-title":"Endocrinology"},{"key":"BFnrrheum201548_CR141","doi-asserted-by":"publisher","first-page":"6536","DOI":"10.1073\/pnas.1301620110","volume":"110","author":"AD Redfern","year":"2013","unstructured":"Redfern, A. D. et al. RNA-induced silencing complex (RISC) proteins PACT, TRBP, and Dicer are SRA binding nuclear receptor coregulators. Proc. Natl Acad. Sci. USA 110, 6536\u20136541 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrrheum201548_CR142","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s11914-013-0143-6","volume":"11","author":"AJ van Wijnen","year":"2013","unstructured":"van Wijnen, A. J. et al. MicroRNA functions in osteogenesis and dysfunctions in osteoporosis. Curr. Osteoporos. Rep. 11, 72\u201382 (2013).","journal-title":"Curr. Osteoporos. Rep."},{"key":"BFnrrheum201548_CR143","doi-asserted-by":"publisher","first-page":"R179","DOI":"10.1530\/JME-13-0294","volume":"52","author":"B Gamez","year":"2014","unstructured":"Gamez, B., Rodriguez-Carballo, E. & Ventura, F. MicroRNAs and post-transcriptional regulation of skeletal development. J. Mol. Endocrinol. 52, R179\u2013197 (2014).","journal-title":"J. Mol. Endocrinol."},{"key":"BFnrrheum201548_CR144","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/jbmr.1491","volume":"27","author":"J Delgado-Calle","year":"2012","unstructured":"Delgado-Calle, J. et al. DNA methylation contributes to the regulation of sclerostin expression in human osteocytes. J. Bone Miner. Res. 27, 926\u2013937 (2012).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrrheum201548_CR145","doi-asserted-by":"publisher","first-page":"83","DOI":"10.4161\/epi.7.1.18753","volume":"7","author":"J Delgado-Calle","year":"2012","unstructured":"Delgado-Calle, J. et al. Role of DNA methylation in the regulation of the RANKL-OPG system in human bone. Epigenetics 7, 83\u201391 (2012).","journal-title":"Epigenetics"},{"key":"BFnrrheum201548_CR146","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1126\/science.273.5279.1236","volume":"273","author":"BD Gelb","year":"1996","unstructured":"Gelb, B. D., Shi, G. P., Chapman, H. A., & Desnick, R. J. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273, 1236\u20131238 (1996).","journal-title":"Science"},{"key":"BFnrrheum201548_CR147","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s11914-014-0220-5","volume":"12","author":"I Fijalkowski","year":"2014","unstructured":"Fijalkowski, I., Boudin, E., Mortier, G. & van Hul, W. Sclerosing bone dysplasias: leads toward novel osteoporosis treatments. Curr. Osteoporos. Rep. 12, 243\u2013251 (2014).","journal-title":"Curr. Osteoporos. Rep."},{"key":"BFnrrheum201548_CR148","doi-asserted-by":"crossref","unstructured":"Tella, S. H. & Gallagher, J. C. Biological agents in management of osteoporosis. Eur. J. Clin. Pharmacol. (2014).","DOI":"10.1007\/s00228-014-1735-5"},{"key":"BFnrrheum201548_CR149","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1056\/NEJMoa1305224","volume":"370","author":"MR McClung","year":"2014","unstructured":"McClung, M. R. et al. Romosozumab in postmenopausal women with low bone mineral density. N. Engl. J. Med. 370, 412\u2013420 (2014).","journal-title":"N. Engl. J. Med."},{"key":"BFnrrheum201548_CR150","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/jbmr.2351","volume":"30","author":"R Recker","year":"2015","unstructured":"Recker, R. et al. A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density. J. Bone Miner. Res. 30, 216\u2013224 (2015).","journal-title":"J. Bone Miner. Res."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2015.48.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2015.48","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2015.48.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T14:46:26Z","timestamp":1717857986000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrrheum.2015.48"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,21]]},"references-count":150,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["BFnrrheum201548"],"URL":"https:\/\/doi.org\/10.1038\/nrrheum.2015.48","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,21]]},"assertion":[{"value":"21 April 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2015","order":2,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Erratum","order":3,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the version of this article initially published online, Figure 3 contained a typographical error (alchohol instead of alcohol). The error has been corrected for the print, HTML and PDF versions of the article.","order":4,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}